Zsolt Mikuska

Zsolt Mikuska currently serves as Regional Therapeutic Area Lead Inflammation at Boehringer Ingelheim, a position held since July 2024. Previously, Zsolt Mikuska was Associate Director and Program Operational Leader at MorphoSys from January 2022 to June 2024. Zsolt Mikuska's extensive experience at Boehringer Ingelheim spans from 2008 to 2021, featuring roles such as Process Lead Site Preparation and Supply Management, IMP Distribution Strategy Clinical Supplies Expert, Regional Therapeutic Area Lead for Metabolics and CNS, Group Leader for Regional Documentation Management, Clinical Trial Leader, and Regional Clinical Trial Manager. Prior roles include Senior CRA at PPD and CRA at HungaroTrial CRO, along with a research associate position at the Agricultural Biotechnology Centre. Zsolt Mikuska holds a Master's Degree in Agricultural Sciences with a specialization in Molecular Genetics and Biotechnology from St Stephen University in Hungary.